TY - JOUR
TI - Long-Term Survival under Arterial Chemoembolization and Sorafenib of a
Patient with Hepatocellular Carcinoma and Tumor Atrial Thrombus: A Case
Report and Literature Review
AU - Mavroudis, Andreas
AU - Cholongitas, Evangelos
JO - Gastrointestinal Tumors
PY - 2020
VL - 7
TODO - 4
SP - 156-161
PB - Karger
SN - 2296-3774, 2296-3766
TODO - 10.1159/000509186
TODO - Hepatocellular carcinoma; Right atrium tumor thrombus; Sorafenib;
Transarterial chemoembolization
TODO - Hepatocellular carcinoma (HCC) is considered to be the fourth most
frequent cause of cancer-associated death globally. HCC might be
associated, especially in advanced stages, with the formation of tumor
thrombus (TT), which can be located in the portal vein, as well as in
hepatic and/or inferior vena cava (IVC) veins. Nevertheless, the
extension of TT to the right atrium (RA) is infrequent with an
unfavorable prognosis. We present a rare case of a male patient with HCC
and IVC TT extending to the RA. The atrial thrombus was the first
manifestation of HCC diagnosed by cardiac ultrasound. So far, the
patient has undergone 4 courses of transarterial chemoembolization in
combination with systemic therapy with sorafenib, and under this
therapeutic approach long-term survival has been achieved.
ER -